Wissenschaftliche Arbeiten

Doç. Dr. Zeynep Yegin Katran

60 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Venom Immunotherapy in Clinical Practice: A Retrospective Real-World Cohort

    Toxins, 2026

    DOI 10.3390/toxins18100447 PMID 42931540 Frei zugänglicher VolltextQuelle: ORCID

  2. Is local anaesthetic drug allergy really common? A 10-year single-centre retrospective analysis

    Allergologia et Immunopathologia, 2026

    DOI 10.15586/aei.v54i4.1661 PMID 42433054 Frei zugänglicher VolltextQuelle: ORCID

  3. Psychiatric Burden in Adult Patients with Common Variable Immunodeficiency: A Single-Center Cross-Sectional Study

    Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 2026

    DOI 10.36516/jocass.1907239 Frei zugänglicher VolltextQuelle: ORCID

  4. ASTHMA PHENOTYPES AND COMORBID DISEASES

    International Archives of Allergy and Immunology, 2026

    DOI 10.1159/000552377 PMID 42207732 Quelle: ORCID

  5. Clinical Outcomes of Cat Allergen Immunotherapy in Patients With Allergic Rhinitis: A Real-World Study

    Journal of Craniofacial Surgery, 2026

    DOI 10.1097/scs.0000000000012723 PMID 41911585 Quelle: ORCID

  6. Real-Life Outcomes of Oral Provocation Testing with Alternative NSAIDs in NSAID Hypersensitivity

    Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 2026

    DOI 10.36516/jocass.1852177 Frei zugänglicher VolltextQuelle: ORCID

  7. Severe Asthma, Allergen Sensitization, and Chronic Rhinosinusitis: A 10-Year Real-Life Cohort Study

    Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 2026

    DOI 10.36516/jocass.1852216 Frei zugänglicher VolltextQuelle: ORCID

  8. Acil Serviste Kronik Spontan Ürtiker Yönetimi

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4019.c3278 Quelle: ORCID

  9. Güncel Acil Tıp Çalışmaları VIII

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4019 Frei zugänglicher VolltextQuelle: ORCID

  10. Herediter Anjiödem ve Acil Serviste Yönetimi

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4019.c3279 Quelle: ORCID

  11. Adult IgE-mediated food allergy: clinical characteristics, predictors of severe reactions, and total IgE cut-off

    Allergologia et Immunopathologia, 2026

    DOI 10.15586/aei.v54i1.1548 PMID 41510933 Frei zugänglicher VolltextQuelle: ORCID

  12. Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: insights from a cohort of 527 patients

    Allergologia et Immunopathologia, 2026

    DOI 10.15586/aei.v54i1.1579 PMID 41510935 Frei zugänglicher VolltextQuelle: ORCID

  13. Primary and steroid-induced antibody deficiency in severe asthma: a real-life analysis of a well-defined biologic-treated cohort

    Journal of Asthma, 2026

    DOI 10.1080/02770903.2026.2644881 PMID 41841266 Quelle: ORCID

  14. Primary and Steroid-Induced Antibody Deficiency in Severe Asthma: A Real-Life Analysis of a Well-Defined Biologic-Treated Cohort

    Figshare, 2026

    DOI 10.6084/m9.figshare.31771285 Frei zugänglicher VolltextQuelle: OpenAlex

  15. Mind, Mucosa, and Skin: The Triad of Urticaria, Allergic Rhinitis, and Psychological Disorders

    Journal of Craniofacial Surgery, 2026

    DOI 10.1097/scs.0000000000012581 PMID 41842758 Quelle: OpenAlex

  16. Omalizumab and food allergy: does reaction severity improve in adult patients?

    Advances in Dermatology and Allergology, 2026

    DOI 10.5114/ada.2026.161822 PMID 42889680 Frei zugänglicher VolltextQuelle: OpenAlex

  17. Mast cell activation syndromes in clinical practice: diagnostic challenges, phenotypes, and real-life management

    Advances in Dermatology and Allergology, 2026

    DOI 10.5114/ada.2026.162040 PMID 42890065 Frei zugänglicher VolltextQuelle: OpenAlex

  18. HYPERSENSITIVITY REACTIONS TO ANTI-TUBERCULOSIS AGENTS

    Turkiye Klinikleri eBooks, 2026

    DOI 10.5336/978-625-5439-04-8_p117 Quelle: OpenAlex

  19. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry

    Respiratory Medicine, 2025

    DOI 10.1016/j.rmed.2024.107883 PMID 39617354 2 Zitationen (Europe PMC) Quelle: ORCID

  20. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry

    The Journal of asthma : official journal of the Association for the Care of Asthma, 2025

    DOI 10.1080/02770903.2025.2466182 PMID 39932533 4 Zitationen (Europe PMC) Quelle: Europe PMC

  21. Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registry

    The Journal of asthma : official journal of the Association for the Care of Asthma, 2025

    DOI 10.1080/02770903.2025.2493134 PMID 40238182 Quelle: Europe PMC

  22. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

    Clinical and Translational Allergy, 2025

    DOI 10.1002/clt2.70018 PMID 39865387 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i1.1183 PMID 39786871 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. Identifying future risk factors of uncontrolled asthma control: the TAAR study perspective

    Journal of Asthma, 2025

    DOI 10.1080/02770903.2025.2592244 PMID 41305966 1 Zitation (OpenAlex) Quelle: OpenAlex

  25. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry

    Bratislavské lekárske listy/Bratislava medical journal, 2025

    DOI 10.1007/s44411-025-00104-w Frei zugänglicher VolltextQuelle: OpenAlex

  26. Evaluation of bronchial mucoza and minor salivary gland byopsy in patients with sarcoidosis by flow volume maneuver

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i6.1516 PMID 41229048 Frei zugänglicher VolltextQuelle: ORCID

  27. A practical and applicable desensitization scheme for ciprofloxacin with a glass of water

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i5.1413 PMID 40923430 Frei zugänglicher VolltextQuelle: ORCID

  28. Antituberculosis drug–induced hypersensitivity: clinical characteristics and risk factors

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i5.1427 PMID 40923422 Frei zugänglicher VolltextQuelle: ORCID

  29. Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study

    International Archives of Allergy and Immunology, 2025

    DOI 10.1159/000548107 PMID 40875753 Quelle: ORCID

  30. A rare case of type IV hypersensitivity: Prilocaine allergy

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i4.1382 PMID 40682238 Frei zugänglicher VolltextQuelle: ORCID

  31. Fewer injections, less pain: Successful cyanocobalamin desensitization

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i3.1320 PMID 40342128 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  32. The cause of perioperative hypersensitivity in adults and consequences of subsequent anesthesia

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i2.1281 PMID 40088030 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  33. Old Questions, new answers: real-world long-term efficiency of hymenoptera venom immunotherapy: prevalance of venom-induced anaphylaxis, risk factors, and field sting reactions

    Allergologia et Immunopathologia, 2025

    DOI 10.15586/aei.v53i2.1237 PMID 40088026 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  34. Rapid drug desensitization with chemotherapy: when should omalizumab be considered?

    Allergologia Et Immunopathologia, 2025

    DOI 10.15586/aei.v53i4.1349 PMID 40682225 Frei zugänglicher VolltextQuelle: ORCID

  35. Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa3664 Quelle: OpenAlex

  36. Anaphylaxis in a country where Asia and Europe meet: Evaluation according to World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) diagnostic criteria

    World Allergy Organization Journal, 2024

    DOI 10.1016/j.waojou.2024.100962 PMID 39310371 Frei zugänglicher VolltextQuelle: ORCID

  37. Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization scheme

    Advances in Dermatology and Allergology, 2024

    DOI 10.5114/ada.2024.142187 PMID 39290905 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  38. Results of patch testing to the European Baseline Series rgolo b i dd in adult patients in Turkey: a five-year experience at a tertiary reference center

    Polish Journal of Allergology, 2024

    DOI 10.5114/pja.2024.135510 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  39. Two Difficult Pandemics: Tuberculosis and COVID-19

    International Journal of Mycobacteriology, 2024

    DOI 10.4103/ijmy.ijmy_189_23 PMID 38771276 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  40. Picturing asthma in Turkey: results from the Turkish adult asthma registry

    Journal of Asthma, 2023

    DOI 10.1080/02770903.2023.2206902 PMID 37096963 17 Zitationen (Europe PMC) Quelle: ORCID

  41. Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?

    Journal of Asthma, 2023

    DOI 10.1080/02770903.2023.2293062 PMID 38060588 4 Zitationen (OpenAlex) Quelle: OpenAlex

  42. Aeroallergen sensitivity in severe asthma

    Allergy, 2023

    Quelle: ORCID

  43. Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

    Astim Allerji Immunoloji, 2023

    DOI 10.21911/aai.203 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  44. Chemotherapy induced hypersensitivity reaction: What did we do so far?

    Allergy, 2023

    Quelle: ORCID

  45. Delayed anaphylaxis due to Alpha-gal allergy: A modified desensitization protocol with red meat in an adult patient,Alfa-gal alerjisine bağlı gecikmiş anafilaksi: Yetişkin bir hastada kırmızı et ile modifiye desensitizasyon protokolü

    Tuberkuloz Ve Toraks, 2023

    DOI 10.5578/tt.20239714 PMID 37740636 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  46. Drug hypersensitivity in drug-resistant tuberculosis

    World Allergy Organization Journal, 2023

    DOI 10.1016/j.waojou.2023.100778 PMID 37251814 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  47. Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study,Ağır eozinofilik astımlı hastalarda mepolizumab etkinliği: Bir gerçek yaşam çalışması

    Tuberkuloz Ve Toraks, 2023

    DOI 10.5578/tt.20239918 PMID 37345397 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  48. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences

    International Archives of Allergy and Immunology, 2023

    DOI 10.1159/000530959 PMID 37442106 3 Zitationen (Europe PMC) Quelle: ORCID

  49. Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to mepolizumab: A case report

    Allergy, 2023

    Quelle: ORCID

  50. Treatment of antituberculosis drug induced dress syndrome with mepolizumab

    Allergy, 2023

    Quelle: ORCID